Table 4.
Prevalence of male and female patients in the COVID-19 clinical categories according to age.
| Female | Male | ||||
|---|---|---|---|---|---|
| Total (n = 2585) | Age < 50 y (n = 289) | Age ≥ 50 y (n = 765) | Age < 50 y (n = 317) | Age ≥ 50 y (n = 1214) | |
| COVID Outcome Scale, No. (%) | |||||
| Cat. 1 (Death) | 164 (6.34) | 2 (0.69) | 68 (8.89) ** | 1 (0.32) | 93 (7.66) ** |
| Cat. 2 (Invasive mechanical ventilation) | 180 (6.96) | 6 (2.08) | 36 (4.71) * | 23 (7.26) ° | 115 (9.47) ° |
| Cat. 3 (CPAP/BiPAP) | 584 (22.59) | 24 (8.30) | 163 (21.31) ** | 55 (17.35) ° | 342 (28.17) ** |
| Cat. 4 (Hospitalized, receiving supplemental low-flow oxygen) | 850 (32.88) | 37 (12.8) | 291 (38.04) ** | 79 (24.92) ° | 443 (36.49) ** |
| Cat. 5 (Hospitalized, not receiving supplemental oxygen) | 347 (13.42) | 58 (20.07) | 96 (12.55) * | 63 (19.87) | 130 (10.71) ** |
| Cat. 6 (Not hospitalized) | 460 (17.79) | 162 (56.6) | 111 (14.49) ** | 96 (30.28) ° | 91 (7.5) **,° |
* p < 0.05 vs. female age < 50 with Fisher exact test. ** p < 0.001 vs. age < 50 same-sex with Fisher exact test. ° p < 0.001 vs. same age female with Fisher exact test. The percentage reported in the first column refers to the whole cohort (n = 2586). The one reported in the other columns refers to the group of patients with their age and sex reported in the corresponding column.